InMode (STU:154) Valuation Rank


STU:154 InMode Ltd STU:154
81 GF Score
Price €12.71
GF Value €17.07
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is InMode Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

InMode Valuation Rank Related Terms

STU:154
81GF Score
InMode Ltd STU:154
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is InMode (STU:154) Overvalued in 2026?

Based on GuruFocus' analysis, InMode stock appears to be undervalued. The current stock price of €12.71 is trading 25.5% below its estimated GF Value™ of €17.07. GuruFocus considers InMode to be Modestly Undervalued.

Key valuation signals for STU:154:

  • Valuation Rank:
  • GF Value™: €17.07 vs. price of €12.71 (25.5% below fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the STU:154 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

InMode Business Description

Other Exchanges INMD:USA
Address Sha’ar Yokneam, Tavor Building, P.O. Box 533, Yokneam, ISR, 2069206
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
81GF Score

Get the complete analysis for STU:154

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.71
Price
€17.07
GF Value